Clinical trial
A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary…
NCT00257855 · University College London Hospitals, Other · Completed
Key facts
| NCT number | NCT00257855 |
|---|---|
| Title | A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis |
| Official title | A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis: Single Centre, Phase 2 Trial |
| Lead sponsor | University College London Hospitals, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Secondary Progressive Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Lamotrigine |
| Enrollment | 120 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Nov 23, 2005 |
| Last update posted | Feb 8, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: